According to Fortune Business Insights, the diabetes treatment devices market share was valued at USD 10.83 billion in 2018 and is projected to reach USD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period. North America dominated the market, accounting for a 40.44% share in 2018.
